Description: Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin hydrochloride APIs and direct compressive granulates for the pharmaceutical industry. The company was incorporated in 2015 and is headquartered in Oslo, Norway.
Home Page: www.vistin.com
OestensjOeveien 27
Oslo,
0661
Norway
Phone:
47 35 98 42 00
Officers
| Name | Title |
|---|---|
| Mr. Magnus Tolleshaug | Interim CEO, Chief Commercial Officer & Commercial Director |
| Mr. Alexander Karlsen | Chief Financial Officer |
| Mr. Vegard Heggem | VP of Operations |
| Mr. Kjell-Erik Nordby M.B.A., M.Sc. | Chief Exec. Officer (Leave of Absence) |
| Eivind Egeli | Director of Technical Service & Sales |
Exchange: OL
Country: NO
Currency: Norwegian Krone (kr)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 842.5001 |
| Price-to-Book MRQ: | 2.6346 |
| Price-to-Sales TTM: | 2.6407 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 74 |